POD-4 - Podium Session
Podium Session 4: Pediatrics, Pelvic Pain, Sexual Dysfunction, Oncology
Sunday June 26, 2022
|
09:00 to 10:00
Room: Bedeque & Cardigan
Learning Objectives
As a result of attending this session, participants will be able to:
- Appreciate intermediate outcomes of transverse ventral coporotomies for chordee correction
- Understand the protective role of circumcision in children with antenatal hydronephrosis
- Gain insight into the cellular immune microenvironment of Hunner’s lesions
- Better understand the link between testosterone therapy, secondary polycythemia and major cardiovascular events and venous thromboembolism
- Review outcomes of patients undergoing salvage radical cystectomy post-trimodal therapy in Canada
- Understand risk of progression for renal masses < 4cm on active surveillance
Presentations
Dr. / Dr Luis Braga
Ventral curvature greater than 70 degrees after degloving can be successfully corrected by three transverse ventral corporotomies
Dr. / Dr Justin Chan
The role of circumcision in preventing urinary tract infections in children with antenatal hydronephrosis: systematic review and meta-analysis
Mr. / M. Michael Morra
Characterizing the immune and inflammatory microenvironments of Hunner lesions in interstitial cystitis/bladder pain syndrome using imaging mass cytometry: a new look at an old disease
Dr. / Dr Jesse Ory
Secondary polycythemia while on testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in men: insights from a global health research network
Dr. / Dr Landan MacDonald
Outcomes of patients undergoing salvage radical cystectomy post-trimodal therapy: results of a multi-institutional Canadian cohort
Dr. / Dr Ryan McLarty
Risk of local progression during active surveillance for renal masses under 4 cm
